Birch Run Capital Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Birch Run Capital Advisors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-288,200	Closed	-$1.49M	–	22
2019 Q2	$1.49M	Buy	+288,200	New	+$1.3M	0.51%	19

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Birch Run Capital Advisors's PETX Position: Q3 2019 in Review

Birch Run Capital Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 288,200 shares — an estimated $1.49M sold.

Birch Run Capital Advisors first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $1.49M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Birch Run Capital Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Birch Run Capital Advisors sold 288,200 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1.49M.
Birch Run Capital Advisors first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Birch Run Capital Advisors's Aratana Therapeutics, Inc. position peaked at $1.49M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Birch Run Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.